England’s Innovative Medicines Fund Falls Short on Evidence, Serves As Stopgap

 
• By Leela Barham
  
perspectives 2026
England's Innovative Medicines Fund is used primarily to provide interim funding to medicines recommended by HTA body NICE. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from United Kingdom